1 |
Hanafusa, T., Yumoto, Y., and Nouso, K., Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett., 176, 149-158 (2002)
DOI
ScienceOn
|
2 |
Theresa, M. A., Ligand-targeted therapeutics in anticancer therapy. Nature, 2, 750-761 (2002)
|
3 |
Wang, J. X., Sun, X., and Zhang, Z. R., Enhanced brain targeting by synthesis of 3,5-dioctanoyl-5-fluoro-2-deoxyuridine and incorporation into solid lipid nanoparticles. European J. Pharmaceutics Biopharmaceutics, 54, 285-290 (2002)
DOI
ScienceOn
|
4 |
Zhang, Z. R. and Zhang, Q. Z., Comparison of liver targeting effect of mitoxantrone-bovine serum albumin-microspheres with galactosyl-mitoxantrone-bovine serum albumin-microspheres. Chi. J. Hospital Pharmacy, 19, 140-141 (1999)
|
5 |
Oka, Y., Waterland, R. A., and Killian, J. K., M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology, 35, 1153-1163 (2002)
DOI
ScienceOn
|
6 |
Ou, X. H. and Kuang, A. R., The use of insulin as carrier in targeted therapy. J. Biomedical Engineering, 17, 87-90 (2000)
|
7 |
Kurtaran, A., Li, S. R., and Raderer, M., Technetium-99mgalactocyl-neoglycoalyco- albumin combined with iodine-123 Tyr(A14) insulin visualized human hepatocellular carcinomas. J. Nucl. Med., 36, 1875-1881 (1995)
PUBMED
|
8 |
Ehninger, G., Schuler, U., and Porksch, B., Pharmacokinetics and metabolism of Mitoxantrone. Clin. Pharmacokine., 18, 365-80 (1990)
DOI
ScienceOn
|
9 |
Von Horn, H., Tally, M., and Hall, K., Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas. Cancer Lett., 162, 253-260 (2001)
DOI
ScienceOn
|
10 |
Tanaka, S., Sugimachi, K., and Maehara, S., Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma. Surgery, 131, S142-147 (2002)
DOI
PUBMED
ScienceOn
|
11 |
Koutions, G., Stathopoulos, G. P., and Dontas, I., The effect of Doxrubicine and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study. Anticancer Res., 22, 815-820 (2002)
PUBMED
|
12 |
Huynh, H., Chow, P. K., and Ooi, L. L., A possible role for insulin-like growth factor-binding protein-3 autocrine/ paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Differ., 13, 115-122 (2002)
PUBMED
|